ATE50499T1 - Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe. - Google Patents

Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe.

Info

Publication number
ATE50499T1
ATE50499T1 AT86109256T AT86109256T ATE50499T1 AT E50499 T1 ATE50499 T1 AT E50499T1 AT 86109256 T AT86109256 T AT 86109256T AT 86109256 T AT86109256 T AT 86109256T AT E50499 T1 ATE50499 T1 AT E50499T1
Authority
AT
Austria
Prior art keywords
phospholipids
pharmaceutical compositions
compositions containing
flavanolignanes
active substances
Prior art date
Application number
AT86109256T
Other languages
English (en)
Inventor
Ezio Bombardelli
Maria Jose Magistretti
Original Assignee
Inverni Della Beffa Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11184200&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE50499(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Inverni Della Beffa Spa filed Critical Inverni Della Beffa Spa
Application granted granted Critical
Publication of ATE50499T1 publication Critical patent/ATE50499T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Detergent Compositions (AREA)
AT86109256T 1985-07-17 1986-07-07 Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe. ATE50499T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT21603/85A IT1187687B (it) 1985-07-17 1985-07-17 Composizioni farmaceutiche contenenti come principi attivi flavanolignani e fosfolipidi
EP86109256A EP0209037B1 (de) 1985-07-17 1986-07-07 Pharmazeutische Zusammensetzungen mit Gehalt an Flavanolignanen und Phospholipiden als Wirkstoffe

Publications (1)

Publication Number Publication Date
ATE50499T1 true ATE50499T1 (de) 1990-03-15

Family

ID=11184200

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86109256T ATE50499T1 (de) 1985-07-17 1986-07-07 Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe.

Country Status (6)

Country Link
EP (1) EP0209037B1 (de)
JP (1) JPS6222719A (de)
AT (1) ATE50499T1 (de)
CS (1) CS261637B1 (de)
DE (1) DE3669106D1 (de)
IT (1) IT1187687B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1190370B (it) * 1985-06-19 1988-02-16 Zambon Spa Composizione farmaceutica solida per uso orale
IT1201149B (it) * 1987-01-14 1989-01-27 Indena Spa Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche
DE4401902C2 (de) * 1994-01-24 2000-02-03 Madaus Ag Verwendung von Flavolignanen als Adjuvans in der Tumortherapie
DE19501266A1 (de) * 1995-01-18 1996-07-25 Madaus Ag Verfahren zur Herstellung von Flavano-Lignan-Zubereitungen mit verbesserter Freisetzung und Resorbierbarkeit danach erhältliche Zubereitungen und deren Verwendung zur Herstellung von Arzneimitteln
CN1061239C (zh) * 1995-01-20 2001-01-31 李叔文 爱滋病特效治疗剂
US6191121B1 (en) * 2000-04-06 2001-02-20 Nicholas V. Perricone Treatment of skin damage using polyenylphosphatidylcholine
US6979459B1 (en) 2000-04-06 2005-12-27 Perricone Nicholas V Treatment of skin damage using polyenylphosphatidycholine
US6932963B2 (en) 2000-06-23 2005-08-23 Nicholas V. Perricone Treatment of skin wounds using polyenylphosphatidylcholine and alkanolamines
ATE363486T1 (de) 2001-07-27 2007-06-15 Neptune Technologies & Bioress Flavonoide und mehrfach ungesättigte fettsäuren enthaltende natürliche phospholipide maritimen ursprungs sowie deren anwendungen
EP1443949B8 (de) * 2001-10-25 2007-02-28 Vladimir Leko Zusammensetzung zum schutz und zur regeneration von leberstruktur und -funktion
US20050130937A1 (en) 2003-10-22 2005-06-16 Enzymotec Ltd. Lipids containing omega-3 and omega-6 fatty acids
US8052992B2 (en) 2003-10-22 2011-11-08 Enzymotec Ltd. Glycerophospholipids containing omega-3 and omega-6 fatty acids and their use in the treatment and improvement of cognitive functions
US7935365B2 (en) 2003-10-22 2011-05-03 Enzymotec, Ltd. Glycerophospholipids for the improvement of cognitive functions
RU2283114C1 (ru) * 2005-06-07 2006-09-10 Открытое акционерное общество "Нижегородский химико-фармацевтический завод" Композиция, обладающая гепатопротекторной активностью и нормализующая обменные процессы
PL2445472T3 (pl) 2009-06-24 2018-07-31 Lipoid Gmbh Kompozycja do zastosowań kosmetycznych, farmaceutycznych lub dietetycznych
PT2493478T (pt) 2009-10-29 2018-04-03 Acasti Pharma Inc Composições terapêuticas concentradas de fosfolípidos
CN105816422B (zh) 2015-01-05 2020-08-14 天士力医药集团股份有限公司 一种水飞蓟宾注射剂及其制备方法
CN105983016B (zh) 2015-03-23 2023-08-11 天士力医药集团股份有限公司 一种含有水飞蓟宾的药物组合
CN105983015B (zh) * 2015-03-23 2022-01-25 天士力医药集团股份有限公司 一种含有水飞蓟宾、ve的药物组合物
ITUB20155532A1 (it) * 2015-11-12 2017-05-12 St Biochimico Italiano Giovanni Lorenzini Spa Formulazione farmaceutica orale comprendente silibina
AU2018360383A1 (en) 2017-11-02 2020-05-21 Natureceuticals Sdn. Bhd. Extract of orthosiphon stamineus, formulations, and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5060M (de) * 1965-12-22 1967-05-08
FR2343481A1 (fr) * 1976-03-11 1977-10-07 Gerlich Norbert Composition destinee a empecher les lesions des membranes biologiques et a regenerer ces membranes une fois qu'elles ont ete endommagees

Also Published As

Publication number Publication date
CS261637B1 (en) 1989-02-10
DE3669106D1 (de) 1990-04-05
EP0209037B1 (de) 1990-02-28
IT1187687B (it) 1987-12-23
IT8521603A0 (it) 1985-07-17
JPS6222719A (ja) 1987-01-30
EP0209037A1 (de) 1987-01-21
CS545686A1 (en) 1988-07-15

Similar Documents

Publication Publication Date Title
ATE50499T1 (de) Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe.
HUP0100430A2 (hu) Strukturált glicerideket tartalmazó készítmény, valamint alkalmazása zsíroldékony vegyületek felszívódásának fokozására
ATE76747T1 (de) Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
MY118371A (en) Tetrahydrolipstatin containing compositions
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
ATE211387T1 (de) Oral 1alpha-hydroxyprevitamin d
KR930702022A (ko) 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
ATE226815T1 (de) Herstellung von arzneimitteln
DK0724885T3 (da) Pernasal sammensætning og pernasalt præparat indeholdende dette
DE69521693D1 (de) Taxanderivate enthaltende arzneizubereitungen
KR940018089A (ko) 내부조직의 방사선 손상에 대한 예방 및 처치방법
ATE223204T1 (de) Liposomenzusammensetzung
DE59410151D1 (de) Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
IT1263840B (it) Formulazioni orali di ubidecarenone in forma di capsule
MX9205568A (es) Composicion farmaceutica que contiene cantidades de 5-amino-1beta-d-ribofuranosil-imidazol-4-carboxamida.
ITRM910002A1 (it) Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
DK0437294T3 (da) Orale farmaceutiske præparater i enhedsdosisform
ES2059816T3 (es) Sustancias activas fisiologicamente, un procedimiento para la preparacion y composiciones farmaceuticas de las mismas.
ATE110274T1 (de) Mittel zur verbesserung spezifischer eigenschaften des blutes.
ITMI911445A1 (it) Impiego di derivati fosfolipidici per la preparazione di composizioni farmaceutiche aventi attivita' immunosoppressiva
KR870005642A (ko) 디플루니살과 트로메타민의 혼합물
ITMI910133A1 (it) Derivati salini del gliceril fosforil mioinositolo ad attivita' terapeutica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
ATE220325T1 (de) Pharmazeutische verwendungen von zypressen
KR970032876A (ko) 간장질환 치료용 의약 조성물
ITRM910038A1 (it) Composizioni farmaceutiche aventi come principio attivo calcitonina da somministrarsi per via intranasale.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEFA Change of the company name
REN Ceased due to non-payment of the annual fee